Alert date April 24, 2022

VISIT WEBSITE

Covid 19 Related Resource

Contact: PLEASE CONTINUE TO MASK UP -BOTH INSIDE AND OUTSIDE!
Phone: (888) 345-0481

Excerpt …. Accupril is used to treat hypertension which means to lower blood pressure. It can also be used to manage heart failure as adjunctive therapy when added to conventional therapy including diuretics or digitalis.

Although long-term ingestion of Nnitroso-quinapril may be associated with potential increased cancer risk in humans, there is no immediate risk to patients taking the medication. Patients currently taking the products are encouraged to consult with their doctor or health care provider about alternative treatment options for them.

The recalled product lots were distributed nationwide to wholesalers and distributors in the United States and Puerto Rico from December 2019 to April 2022. The full description of the recalled lots is listed below.

NDC Lot Number Expiration Date Strength Configuration/Count
0071-0530-23 DR9639 2023 MAR 31 10 mg 1 x 90 count bottle
0071-0532-23 DX8682 2023 MAR 31 20 mg 1 x 90 count bottle
0071-0532-23 DG1188 2022 MAY 31 20 mg 1 x 90 count bottle
0071-0535-23 DX6031 2023 MAR 31 40 mg 1 x 90 count bottle
0071-0535-23 CK6260 2022 MAY 31 40 mg 1 x 90 count bottle

The FDA has requested that wholesalers and distributors stop distribution and quarantine the product immediately. Those who received the affected products should contact Sedgwick at 888-345-0481 for instructions on how to return their product and how to receive reimbursement.

https://www.mytwintiers.com/news-cat/pitzer-recalls-tablets-due-to-increased-cancer-risk/amp/